Category: Finance
ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint
ASX health sector falls broader market with some key names ailing in reporting season CSL Phase III trial fails to meet primary efficacy endpoint but [more…]
Unicorns Podcast: Revolutionising rubber recycling with Sable’s sustainable solutions
The Unicorns Podcast connects you to some of the best and brightest founders, CEOs, executives, business owners, innovators, entrepreneurs and inspiring leaders who make things [more…]
ASX Small Caps Lunch Wrap: Which senior Yakuza tangled with the wrong ninja this week?
Local markets opened higher this morning, thanks to a steady performance on Wall Street, with some added juice from an upturn in core commodity prices [more…]
Ground Breakers: Rare earths players are enlisting China’s help to try get off the ground
Hastings shares run higher as it announces toll treatment deal with Chinese rare earths producer Deterra still looking at battery metal royalty opportunities as iron [more…]
FDA shows the way for accelerated approval of PharmAust’s monepantel in MND
PharmAust successfully completes a Pre-IND meeting with the US FDA Path outlined to potentially receive accelerated and full approval of monepantel for treatment of MND/ALS [more…]
Resources Top 5: ‘Hi!’ says lithium, ‘I’m still here’… and hunted voraciously in Quebec by Olympio
Olympio Metals’ exploration activities at its Cadillac lithium project in Quebec is advancing ahead of schedule Rare earths hunter Hastings enters a tolling and offtake [more…]
Australian Mines sambas into Phase 2 exploration at its Brazilian projects
Phase 2 exploration begins at the Jequie niobium REE and Resende lithium projects in Brazil Exploration to target 30km x 2.5km thorium anomaly at Jequie [more…]
The Secret Broker: China only gave you 1c in the dollar? C’est la vie!
After 35 years of stockbroking for some of the biggest houses and investors in Australia and the UK, the Secret Broker is regaling Stockhead readers [more…]
Top 10 at 11: Chew toys, Rare Earths and Fake News are the morning’s headlines
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning [more…]
Long Shortz with AROA Biosurgery: A chance at a smoother recovery from a Mastectomy? Thanks Enivo
Stockhead’s Ashtyn Hiron sits down with AROA Biosurgery (ASX:ARX) CEO Dr. Brian Ward to get the short end of the long story on the company’s latest [more…]
